Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022

SELL
$2.77 - $5.0 $31,312 - $56,520
-11,304 Reduced 0.45%
2,517,173 $8.01 Million
Q1 2022

May 13, 2022

SELL
$4.01 - $10.42 $3,187 - $8,283
-795 Reduced 0.03%
2,528,477 $12.2 Million
Q4 2021

Feb 11, 2022

SELL
$8.93 - $14.85 $3,223 - $5,360
-361 Reduced 0.01%
2,529,272 $22.6 Million
Q3 2021

Nov 19, 2021

BUY
$11.46 - $15.77 $28.8 Million - $39.7 Million
2,517,173 Added 20202.03%
2,529,633 $36.5 Million
Q3 2021

Nov 12, 2021

SELL
$11.46 - $15.77 $28.9 Million - $39.7 Million
-2,517,469 Reduced 99.51%
12,460 $180,000
Q2 2021

Aug 13, 2021

BUY
$11.32 - $14.45 $110,290 - $140,786
9,743 Added 0.39%
2,529,929 $36.6 Million
Q1 2021

May 07, 2021

BUY
$12.07 - $29.9 $30.4 Million - $75.3 Million
2,517,598 Added 97279.68%
2,520,186 $34.5 Million
Q4 2020

Feb 12, 2021

BUY
$13.25 - $34.58 $34,291 - $89,493
2,588 New
2,588 $75,000

Others Institutions Holding SQZ

About SQZ Biotechnologies Co


  • Ticker SQZ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 29,248,600
  • Market Cap $1.46M
  • Description
  • SQZ Biotechnologies Company, a clinical-stage biotechnology company, develops cell therapies for patients with cancer, autoimmune, infectious diseases, and other serious conditions. Its lead product candidate is SQZ-PBMC-HPV, from its SQZ Antigen Presenting Cells platform, which is in a Phase I clinical trial as a monotherapy and in combination ...
More about SQZ
Track This Portfolio

Track American International Group, Inc. Portfolio

Follow American International Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on American International Group, Inc. with notifications on news.